2024
|
Invention
|
Mutated fragment of vzv glycoprotein e. Provided herein are fragments of the gE protein of varice... |
|
Invention
|
Lipid compounds and lipid nanoparticle compositions. Provided herein are lipid compounds that can... |
|
Invention
|
Rna transcription template preparation. Provided are novel methods using rolling circle amplifica... |
|
Invention
|
Lipid compound and lipid nanoparticle composition. The present invention relates to a lipid compo... |
|
Invention
|
Lipid compounds and lipid nanoparticle compositions.
Provided herein are lipid compounds that ca... |
|
Invention
|
Nucleic acid vaccines for respiratory syncytial virus (rsv). Provided herein are therapeutic nucl... |
2023
|
Invention
|
Rna circularization. The disclosure relates to novel RNA ribozyme constructs encoding foreign pro... |
|
Invention
|
Lipid nanoparticles comprising sterol-modified phospholipids. Provided is LNPs comprising phospho... |
|
Invention
|
Nucleic acid vaccines for coronavirus.
Provided herein are therapeutic nucleic acid molecules fo... |
|
Invention
|
Utr molecule for increasing protein expression level. The present disclosure relates to a UTR mol... |
|
Invention
|
Multivalent nucleic acid vaccines for coronavirus based on sequences derived from sars-cov-2 delt... |
|
Invention
|
One-step method for synthesis of circular rna. Provided are methods of preparing a circular RNA, ... |
|
Invention
|
Lyophilized formulations and liquid formulations of lipid nanoparticles. Lyophilized formulations... |
|
Invention
|
Composition of lipid nanoparticles. Provided herein are lipid nanoparticle compositions comprisin... |
|
Invention
|
Lipid compound and lipid nanoparticle composition. A lipid compound and a lipid nanoparticle comp... |
|
Invention
|
Nucleic acid vaccines for coronavirus based on sequences derived from sars-cov-2 omicron strains.... |
|
Invention
|
System and method for treating biological sample. The present application relates to the technica... |
|
Invention
|
Nucleic acid vaccines for rabies. Provided herein are therapeutic nucleic acid molecules for mana... |
2022
|
Invention
|
Quadrivalent mrna vaccines for influenza viruses. Provided herein are therapeutic nucleic acid mo... |
|
Invention
|
Lipid compound and lipid nanoparticle composition. The present disclosure relates to a lipid comp... |
|
Invention
|
Nucleic acid vaccines for coronavirus based on sequences derived from sars-cov-2 omicron strain. ... |
|
Invention
|
Lipid compounds and lipid nanoparticle compositions.
Provided herein are sphingomyelin-containin... |
|
Invention
|
Multivalent nucleic acid vaccines for coronavirus based on sequences derived from sars-cov-2 beta... |
|
Invention
|
Nucleic acid vaccines for vzv. Provided herein are therapeutic nucleic acid molecules for managin... |
|
Invention
|
Nucleic acid vaccines for coronavirus based on sequences derived from sars-cov-2 delta strain. Pr... |
|
Invention
|
Polynucleotides encoding interleukin-12 (il-12) and related composition and methods thereof. Prov... |
|
Invention
|
Lipid compounds and lipid nanoparticle compositions. Provided herein are sphingomyelin-containing... |
|
Invention
|
Lipid nanoparticle composition.
Provided herein are lipids that can be used in combination with ... |
|
Invention
|
Nucleic acid vaccines for mutant coronavirus. Provided herein are therapeutic nucleic acid molecu... |
|
G/S
|
Pharmaceuticals for the treatment of viral diseases; human
vaccine preparations; oral vaccine pr... |
|
G/S
|
Pharmaceuticals for the treatment of viral diseases; human vaccine preparations; oral vaccine pre... |
2021
|
G/S
|
pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic d... |
|
G/S
|
Pharmaceutical preparations; chemico-pharmaceutical
preparations; drugs for medical purposes; cu... |